摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-溴己烷-3-酮 | 20434-22-4

中文名称
6-溴己烷-3-酮
中文别名
——
英文名称
6-bromo-3-hexanone
英文别名
bromo-6 hexanone-3;6-bromo-hexan-3-one;6-Bromohexan-3-one
6-溴己烷-3-酮化学式
CAS
20434-22-4
化学式
C6H11BrO
mdl
MFCD20621909
分子量
179.057
InChiKey
IKRZHUJVIDUZQY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    205.0±23.0 °C(Predicted)
  • 密度:
    1.298±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    8
  • 可旋转键数:
    4
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.833
  • 拓扑面积:
    17.1
  • 氢给体数:
    0
  • 氢受体数:
    1

SDS

SDS:52d40e508243f944b04ef2851410f696
查看

反应信息

  • 作为反应物:
    描述:
    6-溴己烷-3-酮 在 4 A molecular sieve 、 对甲苯磺酸 、 sodium iodide 作用下, 以 氯仿 为溶剂, 反应 72.0h, 生成 (4-oxo-hexyl)triphenylphosphonium iodide ethyleneketal
    参考文献:
    名称:
    C3认证。跳过C19的多烯信息素的合成。
    摘要:
    描述了包括全顺式二烯或三烯单元的三种性信息素组分的全合成。从海渠开始,顺式-Wittig反应,通过使用C3均化剂4和方便的phospho盐,可以使我们建立靶标的全顺式跳过的多烯骨架。这些合成比文献中描述的合成短,并且已从起始原料以更好的总产率进行。
    DOI:
    10.1016/s0040-4020(01)86399-7
  • 作为产物:
    描述:
    2-ethyl-3-bromotetrahydrofuran 反应 1.0h, 以75%的产率得到6-溴己烷-3-酮
    参考文献:
    名称:
    Thermal isomerization of 2-ethyl-3-bromotetrahydrofuran
    摘要:
    DOI:
    10.1007/bf00959741
点击查看最新优质反应信息

文献信息

  • Les organocuprates dans une nouvelle synthese d'aminoacides enantiomeriquement purs
    作者:J.A. Bajgrowicz、A. El Hallaoui、R. Jacquier、Ch. Pigiere、Ph. Viallefont
    DOI:10.1016/s0040-4020(01)96546-9
    日期:1985.1
    A new general method of synthesis of optically pure α- amino esters was elaborated during studies on the reaction of organocuprates with tosyl and halogeno derivatives of L-serine and L-homoserine.
    在研究有机铜酸盐与L-丝氨酸和L-高丝氨酸的甲苯磺酰基和卤代衍生物的反应过程中,阐述了一种合成光学纯的α-氨基酯的新通用方法。
  • [EN] BENZODIAZEPINE DERIVATIVES USEFUL IN TREATING A RESPIRATORY SYNCYTIAL VIRUS INFECTION<br/>[FR] DÉRIVÉS DE BENZODIAZÉPINE UTILES DANS LE TRAITEMENT D'UNE INFECTION PAR LE VIRUS RESPIRATOIRE SYNCYTIAL
    申请人:REVIRAL LTD
    公开号:WO2022008912A1
    公开(公告)日:2022-01-13
    Benzodiazepine derivatives of formula (lb) wherein: R1 is H or halo; Y is selected from O, S, SO, SO2 and NR; one or two of V, W and X is or are N or CH and the other one or two is or are CH; R2 is a group selected from C1-C6 alkyl, C1-C6 hydroxyalkyl, C1-C6 haloalkyl, halo, -OR, -NHR", -SOmNR2, -SOmR, nitro, -CO2R, -CN, -CONR2, -NHCOR and -NR11R12; each R is independently H or C1-C6 alkyl; R11 and R12 are each independently H or C1-C6 alkyl; or R11 and R12 form, together with the N atom to which they are attached, either (a) a morpholine ring which is optionally bridged by a -CH2- group linking two ring carbon atoms that are positioned para to each other, or (b) a spiro group of the following formula (b): R" is C3-C6 cycloalkyl; m is 1 or 2; n is 0, 1 or 2; and each of R3 to R10 is independently selected from H, C1-C6 alkyl, halo, -OR, -NR2,-NHR", -SOmNR2, -SOmR, nitro, -CO2R, -CN, -CONR2, -NHCOR, -NR13R14 wherein R13 and R14 form, together with the N atom to which they are attached, a morpholine ring, and the following options (i) to (iii): (i) any two of R3 to R10 that bond to the same carbon atom form a C3-C6 spiro ring; (ii) any two of R3 to R10 that bond to non-adjacent carbon atoms form a C1-C3 bridgehead group linking the carbon atoms to which they are bonded; and (iii) any two of R3 to R10 that bond to adjacent carbon atoms form, together with the carbon atoms to which they are bonded, a C3-C6 cycloalkyl group; and wherein each alkyl group or moiety recited above is linear or branched; and the pharmaceutically acceptable salts thereof are inhibitors of RSV and can therefore be used to treat or prevent an RSV infection.
    公式(lb)的苯二氮平衍生物,其中:R1为H或卤素;Y选自O,S,SO,SO2和NR;V,W和X中的一个或两个为N或CH,另一个或两个为CH;R2为以下基团之一:C1-C6烷基,C1-C6羟基烷基,C1-C6卤代烷基,卤素,-OR,-NHR",-SOmNR2,-SOmR,硝基,-CO2R,-CN,-CONR2,-NHCOR和-NR11R12;每个R独立地为H或C1-C6烷基;R11和R12各自独立地为H或C1-C6烷基;或R11和R12与它们所附着的N原子一起形成(a)可以由连接两个相对位置的环碳原子的-CH2-基桥接的吗啡环,或(b)以下公式(b)的螺环:R"为C3-C6环烷基;m为1或2;n为0、1或2;R3至R10中的每一个独立地选自H,C1-C6烷基,卤素,-OR,-NR2,-NHR",-SOmNR2,-SOmR,硝基,-CO2R,-CN,-CONR2,-NHCOR,-NR13R14,其中R13和R14与它们所附着的N原子一起形成吗啡环,以及以下选项(i)至(iii):(i)任意两个与同一碳原子键合的R3至R10形成C3-C6螺环;(ii)任意两个键合到非相邻碳原子的R3至R10形成连接它们所键合的碳原子的C1-C3桥头基团;(iii)任意两个与相邻碳原子键合的R3至R10与它们所键合的碳原子一起形成C3-C6环烷基;上述每个烷基或基团均为直链或支链;它们的药物学上可接受的盐是RSV的抑制剂,因此可用于治疗或预防RSV感染。
  • Phenolic ethers
    申请人:Zoecon Corporation
    公开号:US04137273A1
    公开(公告)日:1979-01-30
    Novel phenyl derivatives of formula I useful for the control of insects and novel intermediates.
    式I的新型苯基衍生物对于控制昆虫是有用的,同时也有新型中间体。
  • METHOD FOR PRODUCING OPTICALLY ACTIVE ALPHA-SUBSTITUTED PROLINE
    申请人:API CORPORATION
    公开号:US20140127762A1
    公开(公告)日:2014-05-08
    The present invention aims to provide an industrial method practically suitable for producing optically active α-substituted prolines from an acyclic ketone compound by a small number of steps under mild conditions. The present invention relates to a production method of an optically active α-substituted proline (4) and/or an optically active α-substituted prolinamide (5), including (a) reacting an acyclic ketone compound (1) with at least one selected from ammonia, an ammonium salt, primary amine and a salt of primary amine, and a cyanating agent to give a cyclic nitrogen-containing compound (2), (b) hydrating the cyclic nitrogen-containing compound (2) to give an α-substituted prolinamide (3), and (c) resolving the α-substituted prolinamide (3) by one or more of (d) enzymatical hydrolysis, (e) resolution by diastereomeric salt formation, and (f) separation by column chromatography.
    本发明旨在提供一种工业方法,以在温和条件下通过少量步骤从非环状酮化合物中生产光学活性α-取代脯氨酸的方法。本发明涉及一种光学活性α-取代脯氨酸(4)和/或光学活性α-取代脯氨酰胺(5)的生产方法,包括以下步骤:(a)将非环状酮化合物(1)与氨、铵盐、一级胺和一级胺盐和氰化试剂中的至少一种反应,得到环状含氮化合物(2);(b)使环状含氮化合物(2)水合,得到α-取代脯氨酰胺(3);(c)通过(d)酶解水解、(e)对映异构盐形成的分离和/或(f)柱层析分离中的一种或多种方法来分离α-取代脯氨酰胺(3)。
  • A novel carbonyl anion equivalent and its application to the synthesis of aldehydes and ketones
    作者:J.E. Richman、J.L. Herrmann、R.H. Schlessinger
    DOI:10.1016/s0040-4039(01)86891-x
    日期:1973.1
查看更多